secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001437749-24-020489
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q1 revenue $2.2M, net loss narrows to $0.5M; generates positive operating cash flow
--------------------------------------------------------------------------------

- Revenue $2.2M flat YoY, up 19.5% QoQ; gross margin improved to 86.3% from 40% on higher license mix and prior hardware reserve.
- Net loss $0.5M ($0.32/sh) vs $1.7M ($3.51/sh) in Q1'23; operating cash flow positive $0.3M vs $1.9M used.
- Operating expenses cut 9% to $2.4M; cash and equivalents $690K; accounts receivable $710K.
- Expanded biometric deployment with long-term financial client drove license fee revenue up 23.6% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924020489/0001437749-24-020489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924020489/bkyi20240617_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-020489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer